SINTX Technologies to explore strategic options

SINTX Technologies, Inc., Salt Lake City, Utah, USA, has announced that its board of directors has initiated a process to explore potential strategic options for the company. SINTX has multiple business lines focused on technical materials, and has unique capabilities in Additive Manufacturing technologies including Digital Light Projection (DLP) ceramic AM, proprietary resin formulations, and extensive pre-build and post-build processing and characterisation.
In addition to its FDA-approved silicon nitride ceramic spinal fusion devices, the company has developed ceramic-polymer composites, a novel technology that addresses other medical devices, such as implants for lower extremity fusion. Based on extensive peer-reviewed published data, the key advantages of the company’s proprietary medical-grade silicon nitride include its proven biocompatibility, inherent resistance to bacteria and viruses, bone cell stimulation, and ease of radiographic imaging.
TRUSTED BY INDUSTRY’S BIGGEST NAMES
Discover how we help leading brands shape the industry conversation
| Contact us |
More recently, the Company’s femoral head technology has attracted renewed interest from several global partners. The Company’s silicon nitride is also being utilised in several aerospace engine applications, with two long-term supply agreements in this market.
With manufacturing and R&D sites located in Salt Lake City and Millersville, Maryland, the company is also one of the few producers of optical ceramic materials for sensor applications. Other proprietary technologies include the manufacture of high performance, lower cost ballistic materials for opaque armour applications at its subsidiary, SINTX Armor. SINTX Armor is reported to be starting production of a competitively priced body- and vehicle- protective armour product that has undergone successful testing.
“With technologies targeted at the medical, defence, and renewable energy markets, year-over-year growth in revenues, and other commercial opportunities in the pipeline, SINTX will require additional investment and resources. As such, we want to examine all strategic opportunities targeted at maximising shareholder value,” said Sonny Bal, Chief Executive Officer and chairman of SINTX. “We believe that potential partners will find significant value in SINTX’s businesses and capabilities.”























